Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins
- PMID: 32794228
- DOI: 10.1111/all.14557
Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins
Abstract
Background: Atopic dermatitis (AD) is the most common inflammatory skin disease in children, with 30% of all those diagnosed developing chronic or relapsing disease by adolescence. Such disease persistence cannot yet be predicted. The aim of the present study was to predict the natural course of AD using clinical parameters and serum proteins.
Methods: Sera of 144 children with AD (age 0-3 years) were analyzed for IgE and 33 cytokines, chemokines, and growth factors. Patient disease course until the age of 7 years was assessed retrospectively. Unsupervised k-means clustering was performed to define disease endotypes. Identified factors associated with AD persistence at the age of 7 years were validated in children with AD in an independent cohort (LISA Munich; n = 168). Logistic regression and XGBoosting methods followed by cross-validation were applied to predict individual disease outcomes.
Results: Three distinct endotypes were found in infancy, characterized by a unique inflammatory signature. Factors associated with disease persistence were disease score (SCORAD), involvement of the limbs, flexural lesion distribution at the age of 3 years, allergic comorbidities, and disease exacerbation by the trigger factors stress, pollen exposure, and change in weather. Persistence was predicted with a sensitivity of 81.8% and a specificity of 82.4%. Factors with a high impact on the prediction of persistence were SCORAD at the age of 3 years, trigger factors, and low VEGF serum levels.
Conclusion: Atopic dermatitis in infancy comprises three immunological endotypes. Disease persistence can be predicted using serum cytokines and clinical variables.
Keywords: atopic dermatitis; atopic eczema; endotype; predictive biomarker.
© 2020 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
References
REFERENCES
-
- Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109-1122.
-
- Garmhausen D, Hagemann T, Bieber T, et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy. 2013;68(4):498-506.
-
- Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004;113(5):925-931.
-
- Davidson WF, Leung DYM, Beck LA, et al. Report from the National Institute of allergy and infectious diseases workshop on "atopic dermatitis and the atopic march: mechanisms and interventions". J Allergy Clin Immunol. 2019;143(3):894-913.
-
- von Kobyletzki L, Svensson A, Apfelbacher C, Schmitt J. Factors that predict remission of infant atopic dermatitis: a systematic review. Acta Derm Venereol. 2015;95(4):389-394.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
